Announcements tracker
What health authorities announced
2,125 announcements from official sources, each one linking straight to the document that issued it. We record what was announced and who announced it. We do not rewrite it.
- gov.uk: Health and Social CareUnited Kingdom20 Nov 2026
New AI guidance to cut paperwork and free more time for care
Drive for artificial intelligence in social care, as guidance sets out how more social care services can harness digital tools to support care
- gov.uk: UK Health Security AgencyUnited Kingdom19 Nov 2026
Thousands of young children at risk from flu with just over a third of 2-and-3-year olds vaccinated
Parents are being urged to get their young children vaccinated as only over a third of 2-and-3-year olds have received a flu vaccine.
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom19 Nov 2026
MHRA appoints senior NHS executive as new Chief Finance and Commercial Officer
The Medicines and Healthcare products Regulatory Agency (MHRA) has appointed a new Chief Financial and Commercial Officer to drive forward the financial aspects of its new five-year strategy.
- gov.uk: Health and Social CareUnited Kingdom19 Nov 2026
New Men’s Health Ambassador to help improve men’s health
Government launches search for first Men’s Health Ambassador, new local guidance and suicide prevention funding
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom19 Nov 2026
Government backs modernisation of gene therapy definitions
Proposed changes will provide clearer regulatory pathway for certain synthetic gene therapies, supporting life sciences innovation while maintaining safety.
- gov.uk: Health and Social CareUnited Kingdom18 Nov 2026
New Champion to give unpaid carers a stronger voice
Anna Dixon MP appointed as the Champion for Unpaid Carers
- gov.uk: Health and Social CareUnited Kingdom18 Nov 2026
Health and Social Care Secretary speech at King's Fund
Yvette Cooper announced new Neighbourhood Support Teams to deliver personalised care to country's most vulnerable patients to keep people out of hospital.
- gov.uk: Health and Social CareUnited Kingdom18 Nov 2026
New personalised care to keep 1.8 million people out of hospital
Neighbourhood Support Teams announced by Health and Social Care Secretary during speech
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom18 Nov 2026
New MHRA service to support medicines innovation and strengthen UK manufacturing
AdvanceGxP will give developers earlier practical support for advanced manufacturing technologies, accelerating patient access to innovative medicines while strengthening UK manufacturing.
- gov.uk: Health and Social CareUnited Kingdom17 Nov 2026
Minister McGovern speech at the Hospice UK conference
Minister McGovern delivered the keynote speech at the Hospice UK conference in Liverpool.
- gov.uk: Health and Social CareUnited Kingdom17 Nov 2026
The future of palliative and end-of-life care
Minister for Social Care and Mental Health, Alison McGovern, delivered the keynote speech at the Hospice UK conference.
- gov.uk: Health and Social CareUnited Kingdom16 Nov 2026
UK-wide framework puts nurses and midwives at heart of prevention
A new UK-wide framework will help nurses, midwives and nursing associates prevent illness, reduce health inequalities and help more people live well for longer.
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom16 Nov 2026
MHRA launches new programme to tackle evidence gaps on women’s health
Women’s Health Programme aims to support innovation in women’s health and better understand how the risks and benefits of medicines and medical devices may differ for women.
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom13 Nov 2026
MHRA: services during Microsoft outage
We are experiencing problems sending and receiving emails.
- gov.uk: Health and Social CareUnited Kingdom12 Nov 2026
Minister McGovern's social care speech at the NCASC conference
Minister McGovern delivered the keynote speech at the National Children's and Adult's Social Services conference in Liverpool
- gov.uk: UK Health Security AgencyUnited Kingdom12 Nov 2026
Over 400 antibiotic-resistant infections each week in 2025
National surveillance data shows antibiotic resistance continues to worsen.
- gov.uk: UK Health Security AgencyUnited Kingdom12 Nov 2026
Time running out for over 580,000 young people to get 1st dose of MenB
Eligible 18 and 19 year-olds, as well as older first year students at university, have until New Year's Eve to get their first dose.
- gov.uk: Health and Social CareUnited Kingdom12 Nov 2026
More familiar carers and less travel under new social care plans
People receiving care at home are set to benefit from more personalised support from familiar carers under neighbourhood commissioning of social care
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom11 Nov 2026
MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced anal cancer
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved retifanlimab (ZYNYZ) for the treatment of adults with squamous cell carcinoma of the anal canal (SCAC).
- gov.uk: UK Health Security AgencyUnited Kingdom10 Nov 2026
UKHSA issues first cold-health alert of winter 2026/27
A yellow cold-health alert has been issued for the North West and West Midlands regions.
- gov.uk: Health and Social CareUnited Kingdom10 Nov 2026
Minister Alison McGovern speech at the Youth Access Conference
Minister McGovern delivered the keynote speech at the Youth Access Conference in Camden
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom9 Nov 2026
Investigational treatments for lung cancer, Huntington’s disease and Alzheimer's gain Innovation Passports through the Innovative Licensing and Access Pathway
Three innovative medicines with the potential to meet unmet needs in lung cancer, Huntington’s disease and Alzheimer’s disease have been given Innovation Passports, the Medicines and Healthcare products Regulatory…
- gov.uk: Health and Social CareUnited Kingdom9 Nov 2026
£40 million for GPs to keep vulnerable patients out of hospital this winter
Hundreds of thousands of vulnerable patients will receive support from their GP this winter under £40 million programme
- gov.uk: Health and Social CareUnited Kingdom5 Nov 2026
UK citizen returned from DRC for specialist Ebola care
UK government worked with the DRC government and international health partners to bring the patient home on a medical evacuation flight
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom5 Nov 2026
MHRA sets out approach to strengthen patient and public involvement and engagement in medicines and medical device regulation
New plan will broaden participation and make clearer how patient experience informs regulatory decisions, safety and innovation
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom4 Nov 2026
MHRA guidance on its assessment of non-clinical data generated outside OECD system
MHRA issues new guidance on its approach to clinical trial applications that rely on non-clinical safety data generated outside the OECD Mutual Acceptance of Data system.
- gov.uk: Health and Social CareUnited Kingdom4 Nov 2026
New NHS blood test trial to help spot cancers earlier
Tens of thousands of patients to take part in landmark trial to see if blood tests can spot cancers
- gov.uk: UK Health Security AgencyUnited Kingdom3 Nov 2026
UKHSA launches human biomonitoring study
UKHSA is measuring PFAS and other chemicals in blood and urine samples to establish UK exposure levels and inform future health research.
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom3 Nov 2026
Clinical trials for medicines: Inclusion and Diversity Plan pilot findings published
The Health Research Authority (HRA) has published the findings from its pilot on researchers and sponsors of clinical trials and clinical investigations developing and submitting an Inclusion and Diversity Plan.
- gov.uk: Health and Social CareUnited Kingdom3 Nov 2026
One million more scans to help catch cancer sooner
125 more NHS scanners and AI technology are helping deliver a million extra scans each year, supporting earlier cancer diagnosis and faster treatment.
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom2 Nov 2026
MHRA launches patient safety essay competition for MedSafetyWeek
The MHRA reminds patients, parents, carers and healthcare professionals to report suspected side effects through the Yellow Card scheme for MedSafetyWeek 2026.
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom30 Oct 2026
Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disorders
MHRA approves triheptanoin to treat adult and paediatric patients with a group of rare inherited disorders.
- gov.uk: Health and Social CareUnited Kingdom30 Oct 2026
Government accepts advice on spring 2027 COVID-19 vaccinations
Government confirms eligibility for the spring 2027 COVID-19 vaccination programme in line with JCVI advice
- gov.uk: UK Health Security AgencyUnited Kingdom30 Oct 2026
Don’t let a winter bug ruin your Diwali celebrations
UKHSA urges those eligible to get vaccinated as soon as possible – help protect yourself and stop the spread of viruses to family, friends and your community.
- gov.uk: UK Health Security AgencyUnited Kingdom30 Oct 2026
New report shows toll of Chickenpox with over 3,000 infants hospitalised last year
Parents urged to ensure children are protected with free vaccine now available as part of NHS Childhood Vaccination Programme
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom30 Oct 2026
MHRA approves gene-editing treatment for children aged five and over with serious inherited blood disorders
Children aged five and over with severe sickle-cell disease and transfusion-dependent β-thalassemia, can now be treated with Casgevy (exagamglogene autotemcel), following an extension of its UK authorisation by the MHRA.
- gov.uk: Health and Social CareUnited Kingdom30 Oct 2026
Government steps up action on breast cancer
More than 1,000 people join trial testing shorter radiotherapy treatment, potentially saving patients 10 hospital trips.
- gov.uk: UK Health Security AgencyUnited Kingdom29 Oct 2026
TB rates in England stay level in 2025, but need to fall further
UKHSA is reminding people to be aware of TB symptoms to ensure prompt testing and treatment
- gov.uk: Health and Social CareUnited Kingdom29 Oct 2026
Under-18 sales ban on nicotine products and all vapes
Chief Medical Officer responds to restrictions on the sale and promotion of vapes and nicotine products
- gov.uk: Health and Social CareUnited Kingdom29 Oct 2026
Under-18 sales ban extended to nicotine products and all vapes
Government implements new restrictions on the sale and promotion of vapes and nicotine products across the UK
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom27 Oct 2026
New MHRA research puts needle-free Strep A vaccine within reach
Pioneering study by MHRA scientists advances innovative approach to vaccination and promise of vaccine against Strep A.
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom23 Oct 2026
MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults
As with any medicine, the MHRA will keep the safety and effectiveness of deuruxolitinib under close review.
- gov.uk: Health and Social CareUnited Kingdom23 Oct 2026
Steps to Safety initiative introduced in 12 areas across England
Phase 1 of Steps to Safety will enable GP practices across 12 areas in England to connect people experiencing domestic abuse with specialist support.
- gov.uk: Health and Social CareUnited Kingdom23 Oct 2026
New mental health pilot for young people supported by social care
Young people supported by social care in Greater Manchester are set to benefit from a new mental health pilot.
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom23 Oct 2026
MHRA approves new oral treatment for moderate to severe plaque psoriasis
MHRA approves new oral treatment for moderate to severe plaque psoriasis
- gov.uk: Health and Social CareUnited Kingdom22 Oct 2026
Social media campaign urges Brits to get vaccinated for winter
Government launches a social media campaign to promote a new NHS App feature which helps people check their eligibility and book their flu vaccination
- gov.uk: UK Health Security AgencyUnited Kingdom22 Oct 2026
Latest weekly winter virus surveillance data
Report monitoring respiratory viruses for the 2026/27 season.
- gov.uk: UK Health Security AgencyUnited Kingdom22 Oct 2026
UKHSA publishes latest Cold mortality monitoring report
Findings from the report show that 2,200 deaths were associated with cold weather in England during winter 2025 to 2026.
- gov.uk: Health and Social CareUnited Kingdom21 Oct 2026
Faster clinical trials bring cutting-edge treatments to patients
Patients are set to receive cutting-edge treatments as the Government hits its ambitious target to speed up clinical trials
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom21 Oct 2026
Government confirms indefinite recognition of CE marked medical devices
Patients across Great Britain will have continued access to medical devices and in vitro diagnostic devices (IVDs) already approved for the EU market.
- gov.uk: Health and Social CareUnited Kingdom21 Oct 2026
Cosmetic cowboys crackdown continues with new restrictions
The governments crackdown on cosmetic cowboys intensifies with restrictions on high-risk procedures.
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom19 Oct 2026
MHRA authorises plozasiran (Redemplo) for adults with familial chylomicronaemia syndrome
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 October 2026, authorised plozasiran (Redemplo)
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom19 Oct 2026
UK regulator brings new AI and MedTech agenda to AdvaMed
UK’s Medicines and Healthcare products Regulatory Agency (MHRA) sets out its next phase of MedTech and AI regulation to US industry leaders at AdvaMed 2026.
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom18 Oct 2026
MHRA consults on proposals to allow schools to keep spare adrenaline nasal sprays on site
The MHRA is now consulting on proposals that would give schools an additional option to support children at risk of life-threatening allergic reactions.
- gov.uk: Health and Social CareUnited Kingdom17 Oct 2026
£140 million boost to urgent care to ease winter pressures on NHS
£140 million will fund 14 urgent care schemes, with 25 more sites opening for winter, to boost NHS capacity and ease pressure on A&E.
- gov.uk: UK Health Security AgencyUnited Kingdom15 Oct 2026
Data shows almost half of people with flu-like symptoms miss work or school
Flu vaccination remains our best defence against workplace and school absenteeism.
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom15 Oct 2026
Counterfeit weight loss pens worth £2 million seized by MHRA and West Midlands Police
Fake weight loss medicines worth approximately £2 million were seized last night in a raid executed by the Medicines and Healthcare products Regulatory Agency (MHRA) and West Midlands Police.
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom15 Oct 2026
MHRA introduces new safeguards to strengthen antidepressant safety information following major review
New and updated patient information for antidepressant medicines to be introduced following an extensive review involving patients, families and independent experts.
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom14 Oct 2026
MHRA 2030 Strategy to modernise patient-centred regulation for the era of AI and personalised medicines
The Medicines and Healthcare products Regulatory Agency (MHRA) has set out ambitious plans to translate cutting-edge scientific and technological innovation into better health outcomes for patients across all four…
- gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom13 Oct 2026
MHRA authorises Onswik (insulin efsitora alfa) for adults with type 2 diabetes
The new treatment option is administered once weekly, potentially reducing the number of injections from up to 365 a year to 52 for some adults with type 2 diabetes.